The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China PE Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O, Ippolito G, Mchugh ... International Journal of Infectious Diseases 91 (10.1016/j.ijid.2020.01.009 …, 2020 | 3751 | 2020 |
Real-time RT-PCR normalisation; strategies and considerations J Huggett, K Dheda, S Bustin, A Zumla Genes & Immunity 6 (4), 279-284, 2005 | 2336 | 2005 |
Manson's Tropical Diseases G Cook, A Zumla Harcourt Brace Saunders Publishing Group, London 21, 1,0847, 2003 | 1886* | 2003 |
Coronaviruses—drug discovery and therapeutic options A Zumla, JFW Chan, EI Azhar, DSC Hui, KY Yuen Nature reviews Drug discovery 15 (5), 327-347, 2016 | 1857 | 2016 |
Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study A Assiri, JA Al-Tawfiq, AA Al-Rabeeah, FA Al-Rabiah, S Al-Hajjar, ... The Lancet infectious diseases 13 (9), 752-761, 2013 | 1697 | 2013 |
Hospital outbreak of Middle East respiratory syndrome coronavirus A Assiri, A McGeer, TM Perl, CS Price, AA Al Rabeeah, DAT Cummings, ... New England Journal of Medicine 369 (5), 407-416, 2013 | 1461 | 2013 |
Middle East respiratory syndrome A Zumla, DS Hui, S Perlman The Lancet 386 (9997), 995-1007, 2015 | 1368 | 2015 |
Validation of housekeeping genes for normalizing RNA expression in real-time PCR K Dheda, JF Huggett, SA Bustin, MA Johnson, G Rook, A Zumla Biotechniques 37 (1), 112-119, 2004 | 1262 | 2004 |
Advances in the development of new tuberculosis drugs and treatment regimens A Zumla, P Nahid, ST Cole Nature reviews Drug discovery 12 (5), 388-404, 2013 | 1060 | 2013 |
Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis JA Caminero, G Sotgiu, A Zumla, GB Migliori The Lancet infectious diseases 10 (9), 621-629, 2010 | 742 | 2010 |
The implications of using an inappropriate reference gene for real-time reverse transcription PCR data normalization K Dheda, JF Huggett, JS Chang, LU Kim, SA Bustin, MA Johnson, ... Analytical biochemistry 344 (1), 141-143, 2005 | 722 | 2005 |
Severe acute respiratory syndrome: historical, epidemiologic, and clinical features DSC Hui, A Zumla Infectious Disease Clinics 33 (4), 869-889, 2019 | 683 | 2019 |
Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis NAJ Gillespie SH, Crook AM, McHugh TD, Mendel CM, Meredith SK, Murray SR ... N Engl J Med 17 (371), 1577-1587, 2014 | 662* | 2014 |
Family cluster of Middle East respiratory syndrome coronavirus infections ZA Memish, AI Zumla, RF Al-Hakeem, AA Al-Rabeeah, GM Stephens New England Journal of Medicine 368 (26), 2487-2494, 2013 | 636 | 2013 |
Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice RS Wallis, M Pai, D Menzies, TM Doherty, G Walzl, MD Perkins, A Zumla The lancet 375 (9729), 1920-1937, 2010 | 608 | 2010 |
Immunological biomarkers of tuberculosis G Walzl, K Ronacher, W Hanekom, TJ Scriba, A Zumla Nature Reviews Immunology 11 (5), 343-354, 2011 | 607 | 2011 |
Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test SD Lawn, P Mwaba, M Bates, A Piatek, H Alexander, BJ Marais, ... The Lancet infectious diseases 13 (4), 349-361, 2013 | 581 | 2013 |
Global Tuberculosis Report 2020–Reflections on the Global TB burden, treatment and prevention efforts J Chakaya, M Khan, F Ntoumi, E Aklillu, R Fatima, P Mwaba, N Kapata, ... International journal of infectious diseases 113, S7-S12, 2021 | 573 | 2021 |
Honey-a remedy rediscovered A Zumla, A Lulat Journal of the Royal Society of Medicine 82 (7), 384-385, 1989 | 568 | 1989 |
Reducing mortality from 2019-nCoV: host-directed therapies should be an option MM Alimuddin Zumla, David S Hui, Esam I Azhar, Ziad A Memish Lancet 395 (10224), E35-E36, 2020 | 547 | 2020 |